West Pharmaceutical Services Inc.
Annette F Favorite (Sr. VP & Chief HR Officer) sells WST shares
About this filing
West Pharmaceutical Services Inc. (WST) filed Form 4 (insider transaction) with the SEC on Sep 10, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Annette F Favorite · Sr. VP & Chief HR Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | M · exercise or conversion of a derivative | +2,817 | $83.47 | $235,134.99 | 19,661.5548 | Direct |
| Sep 8, 2026 | S · open-market saleFootnotes F1 | −2,817 | $340.81 | $960,061.77 | 16,844.5548 | Direct |
| Sep 8, 2026 | M · exercise or conversion of a derivative | +2,818 | $83.47 | $235,218.46 | 19,662.5548 | Direct |
| Sep 8, 2026 | S · open-market saleFootnotes F1 | −2,818 | $340.81 | $960,402.58 | 16,844.5548 | Direct |
| Sep 8, 2026 | M · exercise or conversion of a derivative | +2,500 | $89.64 | $224,100.00 | 19,344.5548 | Direct |
| Sep 8, 2026 | S · open-market saleFootnotes F1 | −2,500 | $340.81 | $852,025.00 | 16,844.5548 | Direct |
| Sep 8, 2026 | M · exercise or conversion of a derivativeStock Options (Right to Buy)Footnotes F2 | −2,817 | $0.00 | $0.00 | 2,818 | Direct |
| Sep 8, 2026 | M · exercise or conversion of a derivativeStock Options (Right to Buy)Footnotes F2 | −2,818 | $0.00 | $0.00 | 0 | Direct |
| Sep 8, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3 | −2,500 | $0.00 | $0.00 | 7,524 | Direct |
Footnotes
- F1 The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price.
- F2 This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.
- F3 This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
More WST filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.